Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Barinthus Biotherapeutics ( (BRNS) ) has issued an announcement.
Barinthus Biotherapeutics plc has announced the promotion of Graham Griffiths from Chief Business Officer to Chief Operating Officer, effective September 1, 2024. Griffiths, who joined the company in 2017 and has a rich background in biotech leadership, will see his salary increase to £336,144 with this new role. The promotion is based solely on merit, with no family or insider connections influencing the decision.
For detailed information about BRNS stock, go to TipRanks’ Stock Analysis page.